Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
CMS does not use any cookie based Analytics or tracking on our websites; see details here.
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
25 October 2017
CMS Budapest advised US medical technology company Becton Dickinson on its new plant opened at the Tatabánya industrial park, west of Budapest, following a HUF 6bn investment. The 10,500 square-meter plant will make immunology and cellular biology research reagents used for manufacturing medical products and it will reach full capacity in 2018, when it will make 8,000 different products.
Congratulations to the team led by Senior Associate András Klupács and Real Estate Partner Gábor Czike.